NM_002075.4:c.814G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002075.4(GNB3):​c.814G>A​(p.Gly272Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0593 in 1,613,922 control chromosomes in the GnomAD database, including 3,298 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 208 hom., cov: 32)
Exomes 𝑓: 0.061 ( 3090 hom. )

Consequence

GNB3
NM_002075.4 missense

Scores

6
5
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 10.0

Publications

59 publications found
Variant links:
Genes affected
GNB3 (HGNC:4400): (G protein subunit beta 3) Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit which belongs to the WD repeat G protein beta family. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. A single-nucleotide polymorphism (C825T) in this gene is associated with essential hypertension and obesity. This polymorphism is also associated with the occurrence of the splice variant GNB3-s, which appears to have increased activity. GNB3-s is an example of alternative splicing caused by a nucleotide change outside of the splice donor and acceptor sites. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Jul 2014]
CDCA3 (HGNC:14624): (cell division cycle associated 3) Predicted to be involved in cell division and protein ubiquitination. Located in adherens junction. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004829645).
BP6
Variant 12-6845700-G-A is Benign according to our data. Variant chr12-6845700-G-A is described in ClinVar as Benign. ClinVar VariationId is 1170122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0641 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNB3NM_002075.4 linkc.814G>A p.Gly272Ser missense_variant Exon 9 of 10 ENST00000229264.8 NP_002066.1 P16520-1F1T0G5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNB3ENST00000229264.8 linkc.814G>A p.Gly272Ser missense_variant Exon 9 of 10 5 NM_002075.4 ENSP00000229264.3 P16520-1

Frequencies

GnomAD3 genomes
AF:
0.0452
AC:
6873
AN:
152150
Hom.:
209
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0116
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0418
Gnomad ASJ
AF:
0.0720
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00909
Gnomad FIN
AF:
0.0802
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0657
Gnomad OTH
AF:
0.0455
GnomAD2 exomes
AF:
0.0484
AC:
12177
AN:
251402
AF XY:
0.0488
show subpopulations
Gnomad AFR exome
AF:
0.0104
Gnomad AMR exome
AF:
0.0266
Gnomad ASJ exome
AF:
0.0696
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0792
Gnomad NFE exome
AF:
0.0695
Gnomad OTH exome
AF:
0.0577
GnomAD4 exome
AF:
0.0608
AC:
88879
AN:
1461654
Hom.:
3090
Cov.:
32
AF XY:
0.0596
AC XY:
43335
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.00851
AC:
285
AN:
33478
American (AMR)
AF:
0.0277
AC:
1237
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0702
AC:
1836
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.0148
AC:
1275
AN:
86258
European-Finnish (FIN)
AF:
0.0798
AC:
4262
AN:
53382
Middle Eastern (MID)
AF:
0.0468
AC:
270
AN:
5768
European-Non Finnish (NFE)
AF:
0.0686
AC:
76273
AN:
1111816
Other (OTH)
AF:
0.0569
AC:
3435
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4539
9078
13616
18155
22694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2764
5528
8292
11056
13820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0451
AC:
6868
AN:
152268
Hom.:
208
Cov.:
32
AF XY:
0.0441
AC XY:
3283
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0116
AC:
483
AN:
41544
American (AMR)
AF:
0.0417
AC:
638
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0720
AC:
249
AN:
3460
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00890
AC:
43
AN:
4834
European-Finnish (FIN)
AF:
0.0802
AC:
851
AN:
10610
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0657
AC:
4472
AN:
68018
Other (OTH)
AF:
0.0445
AC:
94
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
329
658
986
1315
1644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0578
Hom.:
1218
Bravo
AF:
0.0420
TwinsUK
AF:
0.0618
AC:
229
ALSPAC
AF:
0.0651
AC:
251
ESP6500AA
AF:
0.0136
AC:
60
ESP6500EA
AF:
0.0681
AC:
586
ExAC
AF:
0.0499
AC:
6059
Asia WGS
AF:
0.00635
AC:
22
AN:
3478
EpiCase
AF:
0.0665
EpiControl
AF:
0.0702

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21675276) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.13
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T;.;T
Eigen
Pathogenic
0.72
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
D;D;D
MetaRNN
Benign
0.0048
T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Uncertain
2.4
M;.;.
PhyloP100
10
PrimateAI
Uncertain
0.72
T
PROVEAN
Pathogenic
-5.0
D;D;D
REVEL
Uncertain
0.32
Sift
Pathogenic
0.0
D;D;D
Sift4G
Benign
0.097
T;T;T
Polyphen
0.97
D;D;.
Vest4
0.30
MPC
0.85
ClinPred
0.032
T
GERP RS
4.6
Varity_R
0.90
gMVP
0.69
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5442; hg19: chr12-6954864; COSMIC: COSV57528327; COSMIC: COSV57528327; API